Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

InflaRx (IFRX) Return on Sales (2022 - 2025)

Historic Return on Sales for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to 90.26%.

  • InflaRx's Return on Sales rose 275500.0% to 90.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 238.42%, marking a year-over-year increase of 727700.0%. This contributed to the annual value of 277.85% for FY2024, which is 3984600.0% up from last year.
  • Latest data reveals that InflaRx reported Return on Sales of 90.26% as of Q3 2025, which was up 275500.0% from 314.27% recorded in Q2 2025.
  • In the past 5 years, InflaRx's Return on Sales ranged from a high of 21476.02% in Q4 2024 and a low of 5343.01% during Q4 2023
  • For the 4-year period, InflaRx's Return on Sales averaged around 804.91%, with its median value being 90.26% (2025).
  • As far as peak fluctuations go, InflaRx's Return on Sales tumbled by -53410100bps in 2023, and later skyrocketed by 268190300bps in 2024.
  • Quarter analysis of 4 years shows InflaRx's Return on Sales stood at 2.0% in 2022, then tumbled by -266646bps to 5343.01% in 2023, then soared by 502bps to 21476.02% in 2024, then tumbled by -100bps to 90.26% in 2025.
  • Its Return on Sales was 90.26% in Q3 2025, compared to 314.27% in Q2 2025 and 347.07% in Q1 2025.